Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Mark Cuban: Mixing Up the Pharmaceutical Landscape

Catherine Kolonko  |  Issue: April 2023  |  April 7, 2023

Hopeful advocates for lower cost medications wonder whether Mr. Cuban’s company, if it succeeds with generic medications, will be able to also tackle the even higher costs of brand name drugs.

One thing is for sure, says Dr. Popovian: From a public affairs perspective, and a policy perspective, a lot more people are paying attention to this issue now that Mr. Cuban is involved.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Catherine Kolonko is a medical writer based in Oregon.

References

  1. Cision PR Newswire. Mark Cuban Cost Plus Drug Company’s online pharmacy launches with lowest prices on 100 lifesaving prescriptions. Mark Cuban Cost Plus Drug Company. 2022 Jan 19.
  2. Homepage of Mark Cuban Cost Plus Drugs. https://www.costplusdrugs.com/. Accessed 2023 Feb 14.
  3. Frequently asked questions: Mark Cuban cost plus drugs company. Mark Cuban Cost Plus Drugs Company. https://www.costplusdrugs.com/faq/. Accessed 2023 Feb 14.
  4. Imatinib generic Gleevec. Last accessed 2022 Dec 2. https://www.goodrx.com/imatinib
  5. Trish E, Van Nuys K, Popovian R. U.S. consumers overpay for generic drugs. USC Schaeffer. Schaeffer Center White Paper Series. 2022 May 21.
  6. Press release: Mark Cuban Cost Plus Drug Company, PBC integrates with Rightway to lower prescription drug costs. Rightway. 2022 Sept 22.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Drug Updates Tagged with:pharmacy benefit managersprescription drug prices

Related Articles

    Super-Group Physician Practices Offer Benefits, But Raise Concerns

    June 15, 2015

    Rheumatologists worried about the future of their private practices might want to consider jumping onto the super group trend that allows physicians and other providers with similar services to team up to share opportunities and minimize financial burdens. The biggest concern for private practice physicians watching the trend but not yet embracing it is fear…

    Generic-Drug Price Fixing: Is It Happening?

    May 17, 2018

    It started with an inhaler. Like many of you, I am a rheuma­tologist. And like you, I see some patients more often their own primary care provider. This is so often the case that I have gradually devolved into their backup, all-purpose doctor. I am the doc they notify when they get hospitalized for pneumonia…

    The Cost of Free Pharmaceutical Services

    October 18, 2019

    The cards sat, untouched, in a corner of my desk. In the 1800s, it was common for American saloons to provide patrons with a free meal. Of course, the meal came with a catch: The meals were predictably salt laden and designed to encourage patrons to drink more beer. Hence was born the expression, “There…

    High Cost of Specialty Drugs Demands Action

    July 6, 2021

    Amid rising drug costs and the growing influence of pharmacy benefit managers on patient care decisions, physicians are increasingly called upon to advocate for affordable, evidence-based treatments for their patients.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences